Key facts
- This page summarizes Christopher Accettella's Form 4 filing for BlackRock Health Sciences Trust II (BMEZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2022, 11:16.
Christopher Accettella - 04 Feb 2022 Form 4 Insider Report for BlackRock Health Sciences Trust II (BMEZ)
- Reporting relationship
- Portfolio Manager
- Issuer ticker
- BMEZ
- Reported as of
- 04 Feb 2022
- Net transaction value
- +$39,348
- SEC form
- 4
- Accepted by SEC
- 08 Feb 2022, 11:16:08 UTC
- Prior SEC filing
- 03 Feb 2022
- Next SEC filing
- 02 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Janey Ahn as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Accettella filed Form 4 for BlackRock Health Sciences Trust II (BMEZ) on 08 Feb 2022.
Change
- Previous filing in this sequence was filed on 03 Feb 2022.
- Current net transaction value: +$39,348.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BMEZ
transaction
Common Stock
Purchase
- Transaction value
- $39,348
- Shares
- +1,800
- Change %
- Price
- $21.86
- Shares after
- 1,800
- Date
- 04 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.